论文部分内容阅读
目的:分析消化不良患者行盐酸伊托必利片疗法的临床效果。方法:调查对象从我院2012年4月-2015年4月接收消化不良患者中抽选,将80例分成两组后行不同疗法,即:对照组(多潘立酮疗法)、实验组(盐酸伊托必利片疗法),评估总体效果。结果:实验组患者疾病缓解率为95.0%(38/40),高于75.0%(30/40)的对照组,有区别(P<0.05);实验组患者不良反应率为5.0%(2/40),低于22.5%(9/40)的对照组,有区别(P<0.05)。结论:临床针对消化不良患者行盐酸伊托必利片疗法作用突出,可改善病症,恢复肠胃功能,值得借鉴。
Objective: To analyze the clinical efficacy of itopride hydrochloride tablets in patients with dyspepsia. Methods: The subjects were drawn from patients with dyspepsia received from April 2012 to April 2015 in our hospital. Eighty patients were divided into two groups and followed by different therapies: control group (domperidone therapy), experimental group Palliative therapy) to assess the overall effect. Results: The remission rate was 95.0% (38/40) in the experimental group and higher than 75.0% (30/40) in the control group (P <0.05). The adverse reaction rate in the experimental group was 5.0% (2 / 40), less than 22.5% (9/40) of the control group, there is a difference (P <0.05). Conclusion: The clinical efficacy of itopride hydrochloride tablets in patients with dyspepsia is outstanding, which can improve the condition and restore the function of gastrointestinal tract, and is worth learning from.